The binary switch gene Sex-lethal (Sxl) must be on in females and off in males to allow the proper elaboration of the appropriate sexual developmental pathway in Drosophila melanogaster. Previous studies suggested a mechanism in which the on/off regulation of Sxl occurs post-transcriptionally at the level of RNA splicing. A critical prediction of this model is that functional Sx/proteins are absent in males but present in females. In this report we show that the expected full-length proteins are only present in female animals. Multiple forms of Sxl protein are found in females, some of which are expressed in a stage-and tissue-specific pattern. Consistent with a role of Sxl proteins in regulating alternate splicing, the proteins are localized in the nucleus where they exhibit a punctate staining pattern. Surprisingly, several minor Sxl proteins appear to be present in specific tissues of both sexes of adults. The possible origin of these species is discussed. We also show that Sx/ expression in the early embryo is sex specific and depends on maternal daughterless and zygotic sisterless-b activity in accordance with the established roles of these genes as positive regulators of Sxl. The onset of Sx/ expression in the germ line occurs later than that in the soma.
feminization of haplo-X (chromosomally male) cells due to activation of downstream genes in the sexual differentiation pathway (Cline 1979 (Cline , 1983a Maine et al. 1985) .
The on/off state of the Sxl gene is set in the early zygote in response to the X/A ratio (Sanchez and N6th-iger 1983; Cline 1984; Gergen 1987) . When the X/A ratio is 1 (in females), the Sxl gene is activated, while it is not activated when the X/A ratio is 1:2 (in males). Two classes of genes have been identified that are required to transduce this primary signal to Sxl. The first group, which includes daughterless (da), generates maternally synthesized components in the egg that appear to function as cofactors in the Sxl activation process after fertilization (Cline 1983a; Cronmiller and Cline 1986) .
They are required to initiate Sxl gene activity but do not themselves determine whether Sxl will be activated. the on state is maintained by a positive autoregulatory activity of Sxl itself (Cline 1984; Bell et al. 1991) . In addition to its autoregulatory function, Sxl controls female development by activating downstream regulatory genes involved in sexual differentiation of the soma and the germ line and by inactivating male-specific dosage compensation functions.
Molecular studies revealed that the Sxl gene encodes a complex set of RNAs that show sex, stage, and tissue specificity (Bell et al. 1988; Salz et al. 1989 ). The first zygotic Sxl transcripts are only present for a very brief period early in embryogenesis when the activity state of Sxl is initially selected (Salz et al. 1989) . These "early" Sxl RNAs appear to be derived from a promoter that is distinct from the one used during most of the life cycle, and it has been suggested that the expression of these early transcripts would be a likely target for upstream genes involved in assessing the X/A ratio {Salz et al. 1989 ). The embryonic RNAs are then replaced by a set of "late" transcripts that are transcribed from a distinct promoter (Salz et al. 1989) . In spite of the fact that Sxl must be on in females and off in males, this late promoter appears to be constitutive and late transcripts are found in both sexes. Thus, once the pathway has been initiated, the on/off regulation of Sxl must be post-transcriptional. Structural analysis of the late female and male RNAs reveals that on/off regulation involves sexspecific differences in splicing. All of the male-specific RNAs have an additional exon that introduces several in-frame stop signals that should terminate translation prematurely. In contrast, this translation-terminating exon is spliced out in the female-specific late Sxl RNAs. This leaves a large ORF that would allow the synthesis of Sxl gene products that include two protein domains sharing homology with a family of RNA-binding proteins (RNP domains). These findings have suggested a model in which regulation of Sxl activity throughout most of the life cycle is determined by sex-specific splicing (Bell et al. 1988; Salz et al. 1989) .
A critical prediction of our model for on/off regulation of Sxl during development is that full-length Sxl protein must be present in females and absent in males. During the late phase, the differences between females and males should reflect post-transcriptional regulation of Sxl at the level of RNA splicing. Early in embryogenesis the difference between females and males should reflect the mechanisms involved in the initial activation of the Sxl gene. In this case, expression of appropriate levels of Sxl protein in the female embryo should be dependent on the functioning of genes upstream in the pathway that are involved in the transduction of the X/A signal. To test this model, we have used anti-Sxl antibodies to examine the sex-, stage-, and tissue-specific distribution of Sxl proteins.
Results

Full-length Sxl proteins are only present in females
As shown in Figure 1 , A and B, sex-specific alternate splicing of the late Sxl transcripts generates female and male mRNAs that differ substantially in their predicted protein-coding capacities. The female transcripts have an ORF that starts in exon 2 and extends for -350 amino acids. The exact length of this ORF varies among different classes of Sxl female RNAs and depends on the pattern of splicing and polyadenylation in the 3' portion of the nascent RNA (only one example is shown in Fig. 1A , the corresponding sequence of which is reported in Bell et al. 1988) . Differential processing of the late Sxl transcripts mainly affects protein-coding sequences at the carboxyl terminus, and all classes of female transcripts are predicted to encode both RNP domains (M. Samuels et al., in prep.) . While the ORF for the different classes of male transcripts also begins in exon 2, the inclusion of an additional male-specific exon, exon 3, interrupts the ORF. It extends for only 126 or 144 bp {depending on which of the two acceptor sites of exon 3 is used; see Bell et al. 1988) . Thus, instead of encoding a -350-amino-acid protein with two RNP domains, the male RNAs are predicted to produce a short peptide of 42 or 48 amino acids, which terminates upstream of the RNP domains.
To test this prediction, we generated monoclonal antibodies against a lacZ-Sxl fusion protein that is encoded by sequences located downstream of the male-specific termination codons in exon 3. These antibodies should recognize epitopes present in female proteins, while the epitopes should not be present in the truncated male peptides. When screening a hybridoma bank prepared from mice immunized with the lacZ-Sxl fusion protein, we obtained 30 lines that detected Sxl epitopes in a q, l O-Sxl fusion protein constructed from the same Sxl cDNA fragment [Fig. 1B) . Several of these lines were used to examine Sxl proteins in D. melanogaster, and they gave essentially the same results.
In the experiment shown in Figure 1C , an immunoblot of protein extracts from female and male animals at different stages of development was probed with one of the anti-SxI monoclonal antibodies. The antibody detected two major cross-reacting protein species of 36 and 38 kD. These proteins were present in female animals at all stages tested. In contrast, the corresponding male stages did not have detectable levels of immunoreactive antigens. These findings are consistent with the general predictions of our model for the late on/off regulation of the Sxl gene.
Tissue-specific distribution of Sxl protein in adult females
The differential processing of nascent Sxl transcripts in adult females generates multiple spliced products that exhibit some tissue specificity (Salz et al. 1989) . Hence, it was of interest to examine Sxl proteins in different tissues from adult females.
The species of Sxl protein in adult female ovaries, abdomens (lacking the ovaries}, thoraces, and heads are shown in Figure 2A . As expected from genetic studies and clonal analysis (Cline 1979; Sanchez and N6thiger 1982} , Sxl proteins were present in all of the female tis- Both fusion proteins lack the first 99 residues of the cF 10RF but retain the two RNP homologous domains. (C) Total proteins extracts were prepared from female and male animals at different developmental stages and separated on a 10% SDS--polyacrylamide gel. Equal amounts of protein were loaded in the corresponding female and male lanes and probed with monoclonal antibodies raised against the 255 carboxy-terminal residues of Sxl protein.
(1 L) First-instar larvae; (2L) second-instar larvae; (3L) third-instar larvae. The spot in the male adult lane is an artifact.
sues examined. However, the different forms of the protein appeared to be preferentially distributed in one tissue or another. The two major cross-reactive antigens (36 and 38 kD) were equally abundant in extracts prepared from both ovaries and heads (see Fig. 2A ). In contrast, in extracts from ovary-depleted abdomens the level of the 36 kD protein was low, while the 38-kD antigen was the p r e d o m i n a n t species. In extracts from thoraces, the only antigen detected was the 38-kD protein (see Fig. 2A (Salz et al. 1987) . Protein extracts prepared from four heads were each loaded in the three lanes to the left, and extracts prepared from two thoraces were each loaded in the three lanes to the right. Cross-reactive material in the male lanes is indicated with arrowheads. tently appeared broader (see Fig. 2B ) than in other female tissues, indicating that they may actually be composed of several nonresolved antigens.
The electrophoretic mobilities of the detected antigens (36--42 kD) are in good agreement with the range of molecular masses predicted from the different ORFs found in Sxl cDNAs (37-41 kD; M. Samuels et al., in prep.) . Hence, much of the diversity in Sxl proteins observed in various tissues of adult females could arise from the alternate and cell-type-specific processing of Sxl transcripts rather than from post-translational modifications of the protein. In support of this possibility, the cF1 Sxl cDNA described by Bell et al. (1988) was found to encode a protein of the same size both in vitro in a reticulocyte translation system (not shown) and in vivo in transformed flies (Bell et al. 1991) . Moreover, the protein encoded by this cDNA comigrates with one of the major female-specific species (the 38 kD) observed in wild-type flies.
Sxl protein in adult males
As a control for the experiments described in the previous section, we also used the Sxl antibody to probe extracts prepared from different male tissues. While Sxl cross-reacting antigens were not detected in blots of whole male extracts (see Fig. 1C ), we were surprised to discover two very weakly stained bands in extracts prepared from adult male heads and thoraces (Fig. 2B) . The two bands recognized by the Sxl antibody in male extracts were smaller (35 and 33 kD) than the two major female Sxl proteins (36 and 38 kD). They were more prominent in extracts from the male head than from the thorax, while neither was found in the male abdomen (not shown). Though these two bands were present at levels estimated to be between 20 and 40 times lower than the major female-specific Sxl bands, they were reproducibly observed in extracts prepared from heads and thoraces. Interestingly, weakly stained bands of approximately the same electrophoretic mobility were also evident in heads and thoraces of adult females.
Two lines of evidence suggest that the Sxl gene encodes the 33-and 35-kD protein species in males. First, these bands were detectable with several different monoclonal lines that presumably recognize different Sxi epitopes. Second, the bands were absent in males carrying deletions of the Sxl gene (Fig. 2B) . Both of the crossreacting bands were absent in head and thorax extracts from Sxl n'zc;2 males (Salz et al. 1987) . The same result was obtained when examining head and thorax extracts from males carrying another Sxl deficiency, Sxl ~vzS° {Salz et al. 1987). Although we suspect that the amino acid sequence of these minor proteins is colinear with most of the sequence for the female-specific Sxl proteins (see Discussion), their smaller size indicates that they must have some differences in structure. Moreover, they apparently do not function like female-specific Sxl proteins as they seem to be unable to impose the female mode of Sxl splicing in males (as evident here from the lack of proteins of female size in the male extract).
Sxl proteins m embryogenesis
Our previous analysis of the developmental profile of Sxl RNAs suggested that there are three distinct phases during embryogenesis [Salz et al. 1989) . The first phase is immediately after fertilization when the developing embryo contains relatively high levels of maternally derived female Sxl RNAs that have been deposited in the egg during oogenesis. In the second phase, the maternal RNAs disappear and a new set of embryonic RNAs are expressed. These embryonic RNAs are thought to be involved in the initial selection of the sexual development pathway, and they represent the first products of zygotic Sxl expression. In the third phase, the embryonic RNAs disappear and are replaced by the late female and male transcripts. This change, which occurs around the time of cellular-blastoderm formation, is thought to represent the transition from early regulation of Sxl during pathway initiation to late post-transcriptional regulation of Sxl.
It was of interest to compare the different phases of Sxl RNA accumulation during embryogenesis with the profile of Sxl proteins products. In Figure 3 , protein extracts prepared from embryos at different stages were probed with anti-Sxl monoclonal antibodies. Maternal Sxl RNA is abundant in unfertilized eggs and early cleavage stages (Salz et al. 1989 ). However, we detected no maternal SxI protein in extracts from unfertilized eggs (not shown) and in the earliest cleavage stages (0-1.5 hr in Fig. 3) . A low level of Sxl protein can first be detected in the next stage, 1.5-3 hr; however, the yield of Sxl protein is very Proteins of staged Oregon-R embryos were separated by SDS-PAGE and transferred to nitrocellulose. The immunoblot was incubated with monoclonal anti-Sxl antibodies. Ages of the embryos are indicated at the top in hours after egg deposition {25°C). Cross-reactive materials are numbered 1-5; bands 1 and 2 comigrate with the abundant 36-and 38-kD antigens, respectively, observed in adult extracts. The nonlabeled bands of lower molecular mass that appear in all lanes are due to cross-reactivity of the secondary antibody used in these immunoblots, as judged from controls processed without the primary antibody (not shown}. A different secondary antibody is used for whole-mount immunostaining.
low and somewhat variable at this stage, probably reflecting the difficulties in accurate staging in mass collections. The abundance of Sxl proteins increased dramatically in the next stage, the 3-to 4.5-hr period. At this point we observed two major antigens of 36 and 38 kD {band 1 and 2), as well as at least three larger, minor antigens (bands 3-5). Since maternal Sxl RNAs disappear at -2 hr, well before Sxl proteins become abundant, it seems likely that these Sxl proteins are the products of Sxl expression in the zygote. The Sxl embryonic RNAs are present between 2 and 4 hr (Salz et al. 1989 ), and we assume that the Sxl proteins detected in the 1.5-to 3-hr interval are translated primarily from these messages. The late female-specific RNAs first appear between 3 and 4 hr. Thus, Sxl proteins detected in the 3-to 4.5-hr interval are likely to be a mixture of embryonic and late species. During the remainder of embryogenesis, the two major bands increase in abundance, reaching a plateau at mid-embryogenesis. In contrast, the relative amounts of the minor larger Sxl proteins are highest in 3-to 6-hr embryos, and these levels start to decline after mid-embryogenesis.
Female-specific Sxl expression during embryogenesis
During embryogenesis, as is the case at other stages in the life cycle, we would expect to find Sxl proteins in females but not in males. To test this prediction, we stained whole mounts of embryos with anti-Sxl antibody. As illustrated in Figure 4 , A and B, two different classes of wild-type embryos were observed: One class gave uniform staining with the anti-Sxl antibody, whereas the other class was completely devoid of staining. We can first unambiguously distinguish stained and unstained embryos during the last nuclear cycle prior to cellularization when the stained embryo has accumu- Figs. 4A and 5B).
The existence of two classes of embryos would be consistent with our expectation that Sxl is expressed only in females. Female-specific expression of Sxl at this stage was demonstrated by three different lines of evidence.
The first is based on analysis of the number of stained and unstained embryos in wild-type and Sxl mutant backgrounds. As expected from the sex ratio in a wildtype population, 50% of the wild-type embryos were uniformly stained, while 50% gave no staining (see Table 1 ). The number of stained embryos was reduced to -2 5 % when the progeny were from mothers and fathers that were heterozygous and hemizygous, respectively, for Sxl deficiences (SxI fPzB° o r SxIIP3Ge; see Table 1 ). These percentages correlate with the number of female progeny expected to carry a functional copy of the Sxl gene. Similar numbers were obtained for a null allele, Sxl rl (Table  1 ). These results demonstrate that antibody staining in embryos depends on the presence of a functional Sxl gene and thus confirm the specificity of the monoclonal antibodies for Sxl protein.
The second line of evidence came from analysis of Sxl protein distribution in gynandromorph embryos. Such embryos are mosaics for male (XO) and female (XX) cells (49) 101 (25) 18 (23) 278 (28) 238 (50) 241 (51) 295 (75) 61 ( (Hall et al. 19761 . As shown in Figure 4 , F-I, a small fraction of embryos from this cross gave a nonuniform, mosaic staining pattern. The nonstained regions in these embryos varied greatly in size, consistent with size variations of XO patches {30-70%) found in surviving mosaic flies (Zusman and Wieschaus 1987) . Mosaic distribution of the protein was already detectable at the blastoderm stage when Sxl is activated [ Fig. 4F ). The third line of evidence came from analysis of Sxl antibody staining pattern in embryos whose sex could be determined on the basis of their phenotype. For this purpose we took advantage of the the X-linked gene folded gastrulation (fog) (Zusman and Wieschaus 1987) . Embryos that are fog-have a distinct morphology that can be detected shortly after the onset of gastrulation. We crossed attached-X females (XX/Y) to fog/Y males carrying a duplication of fog + on the Y chromosome. All male embryos derived from this cross were expected to be hemizygous for fog and, hence, exhibited the folded gastrulation phenotype; whereas female embryos should be phenotypically fog + (either XX/fog or XX/Y). Analysis of the progeny from this cross revealed that all wild-type embryos gave uniform staining, with the Sxl antibodies indicating that female embryos express Sxl (Fig. 4C) . Most of the fog embryos (92%) were completely devoid of staining (Fig. 4D) ; however, 8% stained uniformly with the antibody. We do not understand the reason for this staining at present. It could be due to recombination or stability problems of the attached X or caused by misregulation of Sxl in males carrying the fog chromosome. Further studies are required to distinguish between these possibilities. One quarter of the siblings in this cross had a distinctive phenotype that resulted from the lack of X chromosomes (nullo-X embryos); and, as expected, these did not stain with anti-Sxl antibodies (Fig. 4E) .
Nuclear localization of Sxl proteins
In wild-type embryos, Sxl protein was first detected around the beginning of nuclear cycle 12. The staining was localized in all somatic syncytial nuclei at this stage {Fig. 5A). Moreover, Sxl staining remained associated with the condensed chromosomes during the metasynchronous nuclear divisions. The level of Sxl protein continued to increase in all somatic cells through cellularization. While high levels of protein were found in the somatic nuclei, no staining was observed in the pole cells (Fig. 5B) . The Sxl protein remained preferentially localized in the nucleus during the subsequent stages of embryogenesis. As can be seen in the gastrulating embryo shown in Figure 5C , the interphase nucleus typically displayed dots of heavy staining superimposed on a more diffuse staining in the nucleoplasm. It is likely that the dots correspond to regions of the nucleus where high levels of Sxl protein accumulate. The photomicrograph Figure 5C also demonstrates association of Sxl protein with condensed chromosomes in cells undergoing mitosis.
Nuclear localization was also found at other stages of Drosophila development in all somatic tissue examined. For example, in third-instar larvae strong SxI staining was observed in the polytene nuclei of female salivary glands cells (Fig. 5D) . The punctate pattern of Sxl staining was particularly evident in these polytenized nuclei. These observations suggest that Sxl proteins may be associated with some defined subnuclear structures both in polytenized and diploid nuclei.
Sxl expression depends on da and sis activities
Genetic studies indicated that initiation of Sxl activity in diplo-X embryos requires the maternally inherited product of the da gene (Cline 1978 (Cline , 1983a . To determine what effects da has on the expression of Sxl proteins, we examined Sxl antibody staining pattern in embryos from homozygous da I mothers that were kept at the non-permissive temperature of 25°C. Under these conditions the number of females that eclosed was <1% ( Table 2) . As can be seen in the photographs of embryos shown in Figure 6 , A-D, the da mutation caused a striking perturbation in the pattern of Sxl staining. Instead of the essentially uniform distribution of Sxl protein observed in female progeny of wild-type mothers, Sxl staining in embryos from da ~ mothers was typically restricted to small patches of cells. As shown in Table 2 , slightly less than half the embryos (41%} gave partial staining, and these were presumably females. The remaining embryos (59%) gave no detectable staining (see Fig. 6D ). This class probably consisted of the males plus a few percent of female embryos. No embryos were found that gave a pattern of staining that was uniform. Since female viability was extremely low, these findings would suggest that the spatially restricted expression of Sxl protein observed in many of the embryos does not allow female survival.
The nonuniform distribution of SxI proteins in da ~ progeny was already evident at the earliest stage at which Sxl staining could be detected, the syncytial blastoderm (see Fig. 6A ). The typical staining pattern consisted of an anterior domain that corresponds to the presumptive anterior midgut and posterior head segments and/or a posterior domain that corresponds to the presumptive posterior midgut. sion varied considerably in size and differed from embryo to embryo (see Fig. 6B, C) ; however, even in the more extreme cases, there was usually some residual staining in the maxillary head segment. Cells within the stained domains appeared to express wild-type levels of SxI protein; no intermediate levels were observed. Since the restricted patterns of Sxl expression persisted throughout embryogenesis, it seems likely that once Sxl is activated, it remains on. SxI activation in female embryos requires at least two different zygotically active loci in addition to the maternal da gene product: sis-a and sis-b (Cline 1986 (Cline , 1988a . To determine what effects these elements have on the expression of Sxl proteins, we have examined the antibody staining pattern in embryos mutant in the sis-b element (Fig. 6E-H) . For this purpose, we used the sis-b allele, scute 31 (sis-bSC3-1; Cline 1988a). The viability of homozygous sis-b ~c31 females ranges from 100% at 18°C to < 1% at 29°C, with a very well-defined temperaturesensitive period that begins at nuclear cycle 9 and ends at the beginning of nuclear cycle 14 (T.W. Cline, unpubl.) .
sis-b s~3I progeny were collected at two different temperatures, 18 and 25°C, and stained with anti-Sxl antibody (Table 2) . At the permissive temperature (18°C) the staining pattern resembled that observed in collections of wild-type animals: half of the animals were stained, and Sxl protein appeared to be expressed in all somatic cells of these embryos (Fig. 6E, G) . Unlike the wild-type animals, however, the level of staining in the majority of mutant animals was not the same throughout the embryo. As illustrated by the early gastrulating embryo in Figure 6E , lower levels of staining were consistently observed in cells located in the medial region, while higher levels of staining were found in cells near the anterior and posterior ends of the embryo. Surprisingly, these regional differences in the level of SxI protein persisted through germ-band extension (see Fig. 6G,I ) and could be detected even after germ-band retraction. Since homozygous sis-b "~c'~I females were 100% viable at 18°C, the variable levels of Sxl protein in different cells of the embryo, as shown in Figure 6J , appeared to be tolerated by the animal and were sufficient to support apparently normal female development.
The picture was dramatically changed at 25°C, a temperature at which only 11% of the homozygous females survived (Table 2 ). There was a large reduction in the number of embryos showing staining in all cells and an increase in the number of embryos with regions in which there was no detectable SxI protein. The spatially restricted patterns of Sxl expression were first observed at the syncytial blastoderm stage and persisted throughout the remainder of embryogenesis. Moreover, the altered patterns were reminiscent of those observed in embryos with insufficient levels of maternal da activity. As illustrated in the cellular blastoderm shown in Figure 6F and the germ-band-extended embryo in Figure 6H , most of the embryos showed a band of staining near the anterior and posterior ends, with little or no staining in the medial region. The domains tended to be smaller and the levels gradually decreased under more restrictive conditions. The regions of Sxl expression least likely to be disrupted were located around the anterior and posterior midgut invaginations. At 29°C, when female viability was almost zero, < 1% of the embryos showed any antiSxl staining {J. Hager, pets. comm.)
Discussion
We have tested the post-transcriptional model for on/off regulation of Sxl using antibodies directed against Sxl
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In vivo distgibution of Sex.lethal proteins epitopes that are encoded by mRNA sequences downstream of the male-specific exon. Our results support this model: In females, where Sxl function is required, our antibodies detect a set of protein species of the expected molecular weight. In contrast, these proteins are not detected in male animals where Sxl function must be tumed off. The female-specific proteins can first be detected on immunoblots early in embryogenesis, and they persist through the remainder of the life cycle. Consistent with expectations from earlier genetic studies {Cline 1979; N6thiger 1982, 1983) , antibody staining of embryo whole mounts and dissected tissues from later stages indicates that the SxI protein is present in all female tissue.
The findings that Sxl proteins are preferentially localized in the nucleus where RNA splicing takes place and the punctate Sxl staining pattern in the nucleus resembles that observed for known components of the RNA splicing machinery (see Fu and Maniatis 1990) contribute to the growing body of evidence that Sxl proteins may function directly to control RNA processing. First, the targets of Sxl activities include the genes transformer and Sxl itself, both of which are regulated at the level of RNA splicing (Boggs et al. 1987; Bell et al. 1988 : Salz et al. 1989 Sosnowski et al. 1989) . Second, the predicted sequence of proteins encoded by female Sxl mRNAs has two domains that share homology with a family of RNAbinding proteins (Bell et al. 1988 ). Third, Sxl protein has been shown to bind to RNA in vitro in a sequence-specific manner (Inoue et al. 1990 ). Fourth, ectopic expression of female Sxl protein in transformed male flies imposes the female-specific splicing of Sxl exon 3 (Bell et al. 1991) .
Sxl protein in males
Consistent with the conclusions drawn from genetic analysis {Cline 1978 , 1983a , 1984 Maine et al. 1985} , no full-length Sxl proteins are detectable in males at any stage in the life cycle. However, we were surprised to find that protein extracts from adult males contain several very low-abundance proteins of -33-35 kD, which cross-react with our anti-Sxl antibodies. Although these proteins are clearly smaller than the female-specific Sxl proteins {whether detected by antibody or predicted from known ORFs of cDNAs: M. Samuels et al., in prep.), they nevertheless appear to be derived from the Sxl gene since they are not found in males carrying Sxl deletions. In addition, since our anti-SxI antibodies were generated against protein sequences encoded by exons downstream of the terminating male-specific exon {see Fig. 1 ) , the 33-to 35-kD species must also share epitopes with the female-specific Sxl proteins. In males, these small proteins were found in the adult head and thorax but were not observed in any other tissue or stage in the life cycle. Interestingly, similar low-abundance Sxl proteins can be detected in females. These proteins comigrate with the species found in males and, as in males, are only detected in the head and thorax of adult animals.
What is the origin of these low-abundance Sxl proteins? Based on their similar size and tissue distribution, it seems likely that the proteins observed in adult males and females are the same. Since they are smaller than the major female-specific proteins, one obvious explanation is that they arise by proteolytic cleavage of the fulllength species. This is not an attractive possibility, at least for the proteins in males, since there is no apparent source of larger "precursor" female Sxl protein. Furthermore, experiments with a female Sxl cDNA expressed in adult males show that full-length Sxl protein can be synthesized in this sex and that such a protein is reasonably stable {Bell et al. 1991).
A more likely possibility is that these small proteins are encoded by an ORF that is somewhat shorter than but closely related to the ORF encoding the female-specific proteins. Such an ORF could be present in a very minor population of Sxl mRNAs that have structures different from the major male and female transcripts. Altematively, these smaller proteins could be translated from an initiation codon located downstream of the normal start site in exon 2. Two in-frame AUGs are present in exon 4, which is downstream of the male-specific exon (Bell et al. 1988) . The first of these is in a context that has a poor match to the fly consensus initiation region, while the context of the second AUG has a much better match to the consensus. Proteins initiating from the first codon would lack the first 38 amino acids of the full-length Sxl protein, while proteins initiated from the second would lack the first 48 amino acids. In either case, the predicted molecular mass of the translation products would closely correspond to that of the smaller low-abundance Sxl proteins.
Reinitiation of translation at an AUG downstream of a small ORF is not uncommon and has been documented for a number of eukaryotic mRNAs (for review, see Kozak 1989) . However, since these minor immunoreactive species were also detected in females where Sxl RNAs lack this small upstream ORF, we consider it more likely that leaky scanning rather than reinitiation of translation causes the production of smaller products. Consistent with this possibility, the AUG in exon 2, which is the likely start site for the female-specific Sxl proteins, is in a context that has a poor match to consensus for initiation and, hence, might occasionally be skipped in favor of one of the downstream AUGs.
While these minor products are restricted in their tissue distribution to the heads and thoraxes of adult animals, this apparent tissue specificity need not signify a functional role for the proteins. Rather, it may reflect some tissue-specific features of the translational machinery that enhance leaky scanning. Whatever role these proteins might have, they are clearly unable to turn on the Sxl gene in the female mode. If they could, we would expect to observe female-specific mRNAs and proteins in male heads; however, we do not. The failure of these proteins to activate the female mode of splicing in males could be due to the fact that they are present at such low levels. Altematively, as a consequence of their truncated structure, they may have no regulatory activity.
Cold
Sxl is not expressed in the embryonic germ line
Genetic studies have shown that the regulation and functioning of Sxl in the germ line differs in important ways from that in the soma [for review, see Pauli and Mahowald 19901. The results reported here also indicate a remarkable difference in the behavior of Sxl in these fundamentally distinct tissue types. The germ line is set aside early in Drosophila embryogenesis when the cleavage nuclei migrate to the periphery of the embryo. Nuclei migrating to the posterior end of the embryo form a special cluster of cells, the pole cells, while the remaining somatic nuclei undergo several more nuclear divisions before cellularization takes place. The decision to activate Sxl appears to be made shortly after the somatic nuclei first reach the periphery of the embryo since newly synthesized Sxl proteins can be detected by nuclear cycle 12. In contrast, Sxl is not activated at this time in the germ line, and no nuclear (or cytoplasmic) Sxl protein can be detected in the pole cells. The pole cells remain unstained through the cellular blastoderm stage and into gastrulation when they disappear from view by invaginating into the surrounding somatic tissue. These findings indicate that Sxl activation in the germ line must occur later in development than in the soma and support the notion that Sxl activation in the germ line must involve mechanisms that are different from those used in the soma.
Differential regulation of early Sxl expression
In spite of the presence of high levels of maternally derived Sxl mRNA in unfertilized eggs (Salz et al. 1989) , our results indicate that little, if any, Sxl protein is deposited into the egg during the course of oogenesis. Moreover, since the maternal Sxl mRNAs were found to turn over in the first hours of embryogenesis (Salz et al. 1989) prior to the time when we first detected Sxl proteins, it seems likely that these maternal Sxl messages are not translated in the early embryo. These findings would resolve the issue of a Sxl maternal effect (Cline 1980; Oliver et al. 1988) and support the view that the initial response of the zygotic Sxl gene to the X/A ratio does not require maternally supplied Sxl activity. What mechanisms prevent the deposition of SxI protein in the developing egg or the translation of the maternal Sxl mRNAs in the embryo remain to be determined.
The initial selection of the sexual development pathway in response to the X/A ratio of the zygote involves regulatory mechanisms that are distinct from those that maintain the determined state and control sexual differentiation. Genetic studies have implicated several loci in the activation process. These include the maternal-effect gene da and the zygotically acting numerator element sis-b (sis-b appears to correspond in large part to the T4 transcriptional unit of the acheate-scute complex; Tortes and Sanchez 1989; Parkhurst et al. 1990; Erickson and Cline 1991) . Our analysis of Sxl protein accumulation in early embryos provides molecular evidence that these loci play an important role in the early expression of the Sxl gene. In progeny of da mothers Sxl protein accumulation is abnormal; instead of uniform staining of all somatic nuclei found in wild-type embryos, we observed a spatially variable staining pattern with many nuclei having no detectable Sxl protein. Similar results were obtained with a temperature-sensitive allele of sisb isis-b sc3-I); in this case, the perturbations in Sxi expression were enhanced as the temperature was increased, and no protein could be detected under the most restrictive conditions. Consistent with a role for the da and sis-b gene products in the initial activation of Sxl, the abnormalities in Sxl antibody staining were evident as soon as protein was first detected in the syncytial blastoderm.
Although the results presented here show only that Sxl protein accumulation is affected by cla and sis-b mutations, it is likely that da and sis-b gene products regulate transcription of the early Sxl gene. In previous studies we have identified a distinct set of embryonic Sxl mRNAs (Salz et al. 1989) . They are transcribed from a female-specific promoter that is active for a brief period in the early embryo and encode protein products that are largely colinear with the late female-specific proteins (L. Keyes et al., in prep.) . The Sxl proteins that are first detected in early embryos are probably the translation products of these embryonic RNAs. The early transcripts are initially expressed just prior to the time when Sxl antibody staining is first observed, whereas the late transcripts are expressed after Sxl antibody staining is already evident (L. Keyes et al., in prep.) .
Genetic experiments have shown that sensitivity of Sxl activation to the dose of X/A numerator elements like sis-b is a feature that distinguishes this category of genetic elements from X/A signal transduction elements such as da that also control Sxl expression (Cronmiller and Cline 1986; Cline 1988a) . sis-b, along with sis-a and perhaps other loci, are X-linked genes that function in the zygote to communicate the number of X chromosomes to Sxl. The counting process seems to be based on the specific dose of the gene products from each locus. In contrast, the maternally derived da gene product should be present at the same level in both male and female zygotes. It is not one of the variable components of the counting system but, rather, functions as a cofactor in the Sxl activation process. Our analysis here of the molecular effects of leaky mutations in sis-b and da on the early expression of Sxl suggest that these two different categories of elements may participate in rather different steps in the activation of Sxl. Reductions in the level of matemal da activity appear to affect the level of zygotic Sxl protein produced in an all-or-none fashion at the level of individual embryonic cells, generating a patchy Sxl staining pattern. In contrast, intermediate levels of Sxl protein are observed at the cellular level as sis-b activity is reduced. Since only a single allele each of da and sis-b was examined, neither of which is likely to generate an altered protein product (Cronmiller et al. 1988; T.W. Cline, unpubl.) , it is possible that this difference reflects a peculiarity of one of these mutant alleles; altematively, it could represent a fundamental difference in how the sis-b and da products function in the activation of Sxl expression.
Sxl expression in some regions of the embryo appears to be far more sensitive to reductions in the level of da or sis-b activity than expression in other regions. In view of the difference between da and sis-b just mentioned above, it is curious that the pattern of sensitivity across the embryo is so similar for mutations in both genes. The fact that the expression of scute-alpha (sis-b) during the temperature-sensitive period for its effects on SxI activation is spatially uniform (Carbrera et al. 1987; Romani et al. 1987) , coupled with the fact that the nonuniform staining patterns are so similar for the two mutants, would argue against these regional differences arising from nonuniform distribution of functional da and sis-b products. Instead, it seems more likely that they reflect regional differences in the threshold of da and sis-b activity required for Sxl expression. Regional differences among cells in their sensitivity to the X/A balance have been suggested ever since the pioneering studies on the X/A signal by Dobshansky and Schultz (1934) . It remains to be seen whether these differences have important functional implications for the operation of the sex determination system or are simply fortuitous consequences of the ways in which other regulatory and metabolic networks impinge on the sex determination system under genetically abnormal conditions.
Materials and methods
Strains and culturing
Flies were grown on a standard medium (Cline 1978) at 25°C unless otherwise indicated. All Sxl alleles (with their current, slightly modified designations), marker mutations, and balancers are described in Lindsley and Zimm (1985 , 1987 , 1990 . The allele originally designated as scute 3 1 is referred to here as sis-b sc3-~, as discussed in Cline (1988aj, as well as for the additional reasons (T.W. Cline, unpubl.) that hemizygous mutant females (viable as a consequence of a gain-of-function SxI allele) display only a relatively weak neural phenotype that has combined acheate and scute-alpha character and is not temperature sensitive in any consistent fashion. The Bithorax Complex (Peifer et al. 1987) provides precedent for using different gene names to distinguish among genetically and developmentally separable regulatory elements that control the same transcription unit, as seems to be the case with scute-alpha and sis-b (Erickson and Ctine 1991) .
DNA techniques
The lacZ-Sxl fusion gene was constructed from a female-specific cDNA cF1 (Bell et al. 1988 ) by the following strategy. The original cDNA clone was cut internally with Bali at position 763 (see Bell et al. 1988) and in the 3' polylinker with PstI. The isolated 1.3-kb fragment was then inserted into the HincI1 and PstI cloning sites of Bluescript and recovered as a XhoI-PstI fragment that was cloned into the SalI and PstlI sites of the pTRB expression vector (BOrglin and De Robertis 1987) . This construct fuses lacZ-coding sequences in-frame with the 255 carboxy-terminal residues of Sxl linked by two artificially introduced residues. In addition, a 1.3-kb filled-in BalI-EcoRI flagment of the same cDNA clone was inserted into the bluntended BamHI cloning site of pAR3039 {Studier and Moffat 1986} to obtain a +lO-Sxl fusion gene. On induction, this gene produces a chimeric 610-Sxl protein fusing the 255 carboxy-terminal residues of Sxl downstream of the first 10 residues of the viral T7 gene +10.
Generation of monoclonal antibodies
The tacZ-Sxl antigen was prepared by SDS gel purification from induced JM101 cultures. Female BALB/c mice were injected intraperitoneally with 100 ~g of this antigen in RIBI adjuvant (RIBI ImmunoChem. Research, Inc.) . Spleen cells from these mice were isolated 3 days after the third boost and fused to SP2/0 myeloma cells in the presence of PEG [Boehringer Mannheim) . Parental hybridoma lines were screened with partially purified +10--Sxl fusion protein using a fast procedure described by Hawkes et al. (1982) . The resultant positives were confirmed by testing on immunoblots loaded with bacterial extracts containing induced +lO-SxI antigens and subcloned by limiting dilution.
Western blot analysis
Staged embryos were washed from food plates, dechorionated in 50% bleach, and washed again in phosphate-buffered saline prior to total protein extraction. Adult tissue was dissected in Drososphila Ringer's medium. Protein extracts of these tissues were essentially prepared as described in Driever and NiissleinVolhard (1988) . They were frozen in liquid nitrogen and, while thawing, homogenized in 2x loading buffer, containing 8 M urea. After incubation for 5 rain at 95°C, insoluble material was sedimented and supematant was sonicated in an ultrasonic bath for 30 min to solubilize the viscous DNA content. Subsequently, 10-15 ~1 was applied to each slot on a 10% SDS--polyacrylamide gel. After electrophoresis, protein was transferred to nitrocellulose paper in Tris-glycine buffer for 2 hr at constant 250 mA. To assess the amount of total protein loaded in each lane, the blot was stained with Ponceau S red. After blocking with 5% low fat dry milk powder in TBS/0.05% Tween-20 {Sigma), the blot was incubated overnight with the first antibody (1 : 10 dilution of hybridoma supematant in TBS, 0.05% Tween-20) at 4°C. For subsequent detection of antigenantibody complexes on the blot, we used the alkaline phosphatase-conjugated anti-mouse kit from Promega.
Immunolocalization in whole-mount embryo
Embryos were dechorionized for 2-3 min in full-strength bleach, washed thoroughly in PBS, and incubated in heptanesaturated fixative (4% paraformaldehyde, Polysciences EM grade, in PBS} for 30 min at room temperature. The fixative phase was then removed and replaced with 90% methanol, 10% 0.5 M EGTA. After several vigorous shakes, the devitilinized embryos that sank to the bottom were collected and rinsed several times in the methanol-EGTA solution followed by rinses in plain methanol. For staining, embryos were gradually rehydrated in PBS and incubated with 1% BSA, 1% Triton X-100, in PBS, for 3-4 hr at room temperature. First antibody was applied as a 1 : 10 dilution of hybridoma supematant (0.3 mg/ml of total protein) in PBS, 0.1% BSA, and 0.1% Triton X-100, and incubated overnight at 4°G. After several washes in the same buffer, embryos were treated with biotinylated second antibody for 2 hr at room temperature and subsequently with biotinylated HRPavidin complexes according to the Vectastain protocol (Vector Laboratories). The bound complexes were visualized with a Cold Spring Harbor Laboratory Press on November 4, 2016 -Published by genesdev.cshlp.org Downloaded from DAB detection kit from the same company. Photomicrographs were taken on Ektar 125 (Kodak) with a Zeiss photomicroscope.
Immunostaining of larval tissue
Salivary glands of third-instar larvae were dissected in Drosophila Ringer's medium and fixed in 4% paraformaldehyde, PBS, for 20 rain at room temperature. Tissues were permeabilized and blocked by incubating in 1% BSA, 1% Triton X-100, and PBS for 4 hr at room temperature. Peroxidase staining proceeded as described for embryos (see above).
